[ADDRESS_1059545] Information Sheet  
 
Title:  A Clinical Performance Evaluation of the SARS -COV -[ADDRESS_1059546]: “DART.”  
 
Protocol No.:   E25001  
WIRB® Protocol:   20200985  
Sponsor:   E25 Bio  
 
Principal Investigator:   [INVESTIGATOR_771685], MD  
 [ADDRESS_1059547]  
 Atlantis, FL [ZIP_CODE]  
 
Other Research Sites:   Kendall Regional Medical Center  
[ADDRESS_1059548],  
Miami, FL [ZIP_CODE]      
 
Aventura Hospi[INVESTIGATOR_307] &  Medical Center   
[ADDRESS_1059549],  
Aventura, FL [ZIP_CODE]  
 
Study Related     
Phone Number s:  JFK: 561- 655-8448 (24 hours)  
  Aventura: (305) 682- 7000 
  Kendall:  (305) 223- 3000   
 In general, what is the purpose of the research, how long will you be involved?  
To collect information about the performance of a new experimental rapid test to detect the virus responsible 
for COVID -19. Your participation is expected to only involve the sample collection and to last no longer 
than 1 or 2 days  
 
What is involved with your participation, and what are the procedures to be followed in the research?  
A medical professional with the research staff will collect [ADDRESS_1059550] already given . 
 
What are the likely r isks or discomforts to you?  
This is identical to the sample nasal swab collection you already provided. Temporary irritation and possible 
sensation of needing to sneeze or cough. It is very unlikely but possible that the technician causes temporary 
injury to your nasal passage which may include minor bleeding. Possible inaccurate test result that leads to 
an additional test . There is no anticipated risk or discomfort in providing your saliva. There is also no 
anticipated risk or discomfort in collecting the  serum since this will be from already collected blood 
samples.  
 
What are the likely benefits to you or to others from the research?  
You should not expect any direct benefit to yourself; however, should this product become available to 
everyone, then it ma y provide cheaper and more rapid testing of this virus which may ultimately save lives.    
 
2 IRB APPROVED  
AS MODIFIED  
Apr 25, 2020  
 
 What are the appropriate alternative procedures or courses of treatment, if any, that might be helpful to you?  
Since you have already been tested with the hospi[INVESTIGATOR_771686], there are no further 
testing procedures to you unless an additional swab is necessary.  
 
Additional and more detailed information is provided within the remainder of this information sheet  
 
What will be done only because y ou are in this research study?  
As mentioned previously, the only activities for you include this informed consent process and the collection 
of a nasal swab , saliva, and potential serum . Once this research study is completed, any information that 
could ide ntify you might be removed from any identifiable private information or identifiable biospecimens 
collected and that, after such removal, the information or biospecimens could be used for future research 
studies or distributed to another investigator for f uture research studies without additional informed consent 
from you or your legally authorized representative  
 If you have any questions now or at any time during this Research Study, please contact [CONTACT_771687].  
 
What are the possible discomforts and risks?  
If you have had a nasal swab before, then this will be no different. The way your sample is analyzed by [CONTACT_771688]. The nasal swab can be uncomfortable and may make you want to sneeze 
or cough, but should not cause any permanent problems. There is always a risk of extended irritation or minor injury to your nasal passage, but the swabs used are standard and designed for this collection. Because 
you have already t ested positive or negative for the virus, this additional test should provide very minimal 
risk of additional risk of false positive or false negative results that may require another confirmatory test . 
There is no anticipated risk or discomfort in providi ng your saliva. There is also no anticipated risk or 
discomfort in collecting the serum since this will be from already collected blood samples.  
 There is also a risk of loss of confidentiality .  Your private information will be shared with individuals and  
organizations that conduct or watch over this research, including:  
 
•The research sponsor  
•People who work with the research sponsor  
•Government agencies, such as the Food and Drug Administration  
•The Institutional Review Board (IRB) that reviewed this resear ch 
 
We may publish the results of this research. However, we will keep your name [CONTACT_147300]. We protect your information from disclosure to others to the extent required by 
[CONTACT_2371]. We cannot promise complete secrecy.  
 
How c ould the researchers benefit from this research study?  
The sponsor is paying the study site  for their time and expertise on this study. In general, presenting research 
results helps the career of a scientist. Therefore, the study doctor may benefit if the results of this study are 
presented at scientific meetings or in scientific journals.  
 If you choose to take part in this study, will it cost you anything?  
There will be no cost to you by [CONTACT_96428].  
 
What if you are injured because of the research study?  
If you experience an injury or have questions about any discomforts that you experience while participating 
in this study, please contact [CONTACT_771689].  
[ADDRESS_1059551] to be in th is study?  
Your participation in this study is voluntary. You may decide not to participate or you may leave the study 
at any time. Your decision will not result in any penalty or loss of benefits to which you are otherwise 
entitled.  
 If you leave this stud y for any reason, please contact [CONTACT_771690] . They will tell you how to stop your participation safely.  
 
Can you be withdrawn from this research study?  
Since this a short study, the likeliho od of withdrawal by [CONTACT_771691].  
 
Who would you call if you have any questions?  
Kleper de Almeida, M.D. is the person in charge of this research study.  If you or your representative(s) 
have any questions regarding your participation in this st udy, if you have any questions, concerns, or 
complaints about the research, or in case of study -related injuries, contact [INVESTIGATOR_124].  de Almeida  at the phone 
number listed on the first page of this consent .  
 If you have any questions about the rights you have whi le taking part in this study or if you have questions, 
concerns, inputs or complaints about the research, please contact:  
 
[CONTACT_244734]
® (WIRB®) 
[ADDRESS_1059552], SE Suite 120 Puyallup, Washington [ZIP_CODE] -2115  
Telephone:  1 -[PHONE_6597]  or 360- 252-2500  
E-mail: [EMAIL_6164]
 
 
WIRB is a group of people who perform independent review of research.  WIRB will not be able to answer some study- specific questions, such as questions about appointment times.  H owever, you may contact 
[CONTACT_771692].  
  
Assent:  
•Assent of children and adults lacking capacity is required if the investigator determines the subject is 
capable of providing consent.  
•Documentation of assent is not required.  